Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 December 2005

Current management of differentiated thyroid carcinoma.

Gelsy Lupoli, Francesco Fonderico, Sara Colarusso, Annalisa Panico, Annalisa Cavallo, Lucia Di Micco, Angela Paglione, Luisa Costa, Giovanni Lupoli

Med Sci Monit 2005; 11(12): RA368-373 :: ID: 438949


Papillary and follicular thyroid cancers, together termed differentiatedthyroid cancers (DTC), comprise the majority of thyroid carcinomas and have an optimal prognosis. MostDTCs appear as asymptomatic thyroid nodules. Fine-needle aspiration (FNA) cytology is the first diagnostictest for a thyroid nodule in a euthyroid patient. Surgery is the primary treatment for thyroid cancers.Most clinicians recommend near-total or total thyroidectomy, and then [sup]131[/sup]I ablation therapy, sinceits consequences are minimal and follow-up is facilitated. A total body scan (TBS) is performed 4 to7 days after [sup]131[/sup] I treatment. At a later stage, all patients should be treated with L-tiroxine so asto suppress TSH, and must undergo a periodic evaluation of TSH and thyroglobulin (Tg), the most sensitiveand specific marker of DTC. After 6-12 months, TBS with [sup]131[/sup]I is performed, a technique complementaryto serum Tg evaluation. For this technique, it is also necessary to have a high serum TSH concentration,obtained by withdrawing thyroxine therapy for 4 to 6 weeks. This standard method induces hypothyroidism.An alternative method to the withdrawal of thyroid hormones in the follow-up of DTC patients is to administerrecombinant human TSH (rh-TSH). After the dose of rhTSH, [sup]131[/sup]I is administered, and then TBS can beperformed 48-72 hours later. Currently, several authors have explored the possibility that rh-TSH-stimulatedTg levels may represent the only necessary test to differentiate patients with persistent disease fromdisease-free patients, without performing a diagnostic TBS.

Keywords: Carcinoma - therapy, Risk Factors, Thyroid Neoplasms - therapy

Add Comment 0 Comments

1016 9


01 December 2023 : Editorial  

Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory Infections

Dinah V. Parums

DOI: 10.12659/MSM.943312

Med Sci Monit 2023; 29:e943312


In Press

08 Dec 2023 : Clinical Research  

Association Between Influenza Vaccine Uptake and Health Awareness: A Cross-Sectional Questionnaire-Based St...

Med Sci Monit In Press; DOI:  

04 Dec 2023 : Animal Research  

Effects of Intrathecal Ketamine on Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor and Mech...

Med Sci Monit In Press; DOI:  

01 Dec 2023 : Clinical Research  

Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective St...

Med Sci Monit In Press; DOI:  

30 Nov 2023 : Review article  

Decoding the Neurological Sequelae of General Anesthesia: A Review

Med Sci Monit In Press; DOI:  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750